Related Experiment Videos
Clonazepam vs. neuroleptics as adjuncts to lithium maintenance
G S Sachs1, J B Weilburg, J F Rosenbaum
1Clinical Psychopharmacology Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02176.
Psychopharmacology Bulletin
|January 1, 1990
Summary
Many bipolar disorder patients experience recurring episodes despite lithium treatment. This study explores switching from neuroleptics to clonazepam as an alternative maintenance medication for bipolar patients.
Area of Science:
- Psychiatry
- Pharmacology
- Neuroscience
Background:
- Bipolar disorder often requires long-term management to prevent recurrent mood episodes.
- Lithium is a primary maintenance treatment, but many patients still experience acute recurrences.
- Adjunctive medications, including neuroleptics and anticonvulsants, are used to manage persistent symptoms.
Purpose of the Study:
- To investigate the efficacy of switching from neuroleptic maintenance therapy to clonazepam in patients with bipolar disorder on lithium.
- To compare the outcomes of lithium-clonazepam maintenance versus lithium-neuroleptic maintenance.
Main Methods:
- An open, prospective study design was employed.
- Bipolar patients receiving maintenance treatment with lithium and a neuroleptic were included.
- Participants were assigned to either switch to lithium and clonazepam or continue their existing lithium-neuroleptic regimen.
Main Results:
- Preliminary results are reported from the ongoing study.
- The study aims to assess the effectiveness and tolerability of clonazepam as an alternative maintenance strategy.
Conclusions:
- Clonazepam may represent a viable alternative adjunctive maintenance medication for select bipolar disorder patients.
- Further research is needed to confirm the long-term efficacy and safety of lithium-clonazepam combination therapy.